The report “Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024″, is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period.
The Market growth is largely driven by the growing incidence of chronic health conditions among women, government initiatives to curb population growth, growing demand for contraceptives to prevent unintended pregnancies, and the growing focus on R&D by key players for the development of advanced products. On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth.
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=136585329
Prolia is the largest and fastest-growing segment of the market.
Based on drug, the women’s healthcare market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28). Prolia is the largest and fastest-growing segment of the market. Prolia has shown a considerable year-on-year growth primarily due to increasing unit demand. Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.
The postmenopausal osteoporosis segment is expected to grow at the highest CAGR during the forecast period.
On the basis of application, the women’s healthcare market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications. The postmenopausal osteoporosis segment is expected to grow at a higher CAGR during the forecast period. The growing prevalence of postmenopausal osteoporosis and a high risk of osteoporosis fractures are the prime factors that contribute towards the large share of this segment. Furthermore, the focus of pharmaceutical players on providing effective drugs for postmenopausal osteoporosis also supports the growth of this segment. The postmenopausal osteoporosis segment also holds the largest share of the market owing to these factors.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136585329
North America accounted for the largest share of the women’s health care market in 2019.
The global women’s healthcare market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2018, North America (US and Canada) was the largest and the fastest-growing regional market for women’s healthcare. The major factors supporting market growth include the growing prevalence of PCOS and postmenopausal osteoporosis, increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Also, the high awareness and understanding regarding contraceptives among American women and the easy access to modern contraception as compared to developing countries propel the market growth in this region.
Key players in the women’s healthcare market;
The market is fragmented in nature, with a large number of players, including tier 1 and mid-tier companies competing for market shares. The prominent players in the global market include Bayer AG (Germany), Allergan (Dublin), Merck & Co. (US), Pfizer Inc. (US), Amgen (US), Agile Therapeutics Inc. (US), Ferring Pharmaceuticals (US), Mylan N.V. (US), Lupin (India), Blairex Laboratories (US), and Apothecus Pharmaceutical (US).
Amgen (US): Amgen (US) is one of the leading providers of the women’s healthcare market. The company’s sales and marketing activities are greatly focused on the US and Europe. The company provides Prolia and Xgeva for the treatment of osteoporosis in postmenopausal women. These drugs have shown a year-on-year double-digit value gain as well as volume growth, and constitute the largest share of the market. Amgen’s EVENITY, meant for the treatment of osteoporosis in postmenopausal women, is also in phase 3 of development. It is being developed in collaboration with UCB (Belgium). The company’s high brand recognition and focus on product innovation have helped it to maintain its foothold in the market.
According to the new market research report “Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024″ published by MarketsandMarkets™.How the Market Growth looks like and Industry Segmentation?The Global Women’s HealthCare Market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period.Based on drug, the women’s healthcare market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28).
Prolia is the largest and fastest-growing segment of the market.
Prolia has shown a considerable year-on-year growth primarily due to increasing unit demand.
Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.On the basis of application, the women’s healthcare market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications.
The postmenopausal osteoporosis segment is expected to grow at a higher CAGR during the forecast period.
The growing prevalence of postmenopausal osteoporosis and a high risk of osteoporosis fractures are the prime factors that contribute towards the large share of this segment.
Phototherapy Equipment Market by Type (Long lamp, CFL, LED, Fiber optic), Application (Skin diseases (psoriasis, vitiligo, eczema), Neonatal Jaundice), End-user, Geography (North America (USA, Canada), Europe, Asia-Pacific) - Global Forecast to 2021 MarketsandMarkets: The phototherapy equipment market is projected to reach USD 583.4 million by 2021 from USD 468.2 million in 2016, at a CAGR of 4.5%.
Growth in the phototherapy equipment market is mainly driven by rising incidences of neonatal jaundice in both developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products, and rising adoption of LED-based phototherapy equipment.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174360683 Conventional Phototherapy Equipment type segment to dominate the overall phototherapy equipment market in 2016 Based on type, phototherapy equipment is classified into conventional, LED, and fiberoptic phototherapy equipment.
Conventional phototherapy equipment are further classified in two segments on the basis of type of lamp installed—equipment with fluorescent lamps and equipment with compact fluorescent lamps.Conventional phototherapy equipment segment is expected to account for the largest share in the phototherapy equipment market in 2016.
The significant market share of conventional phototherapy equipment segment can primarily be attributed to factors such as high prevalence of photo-responsive skin diseases such as psoriasis, vitiligo, eczema, and acne, long-term market presence and established clinical safety and efficacy prolife of these equipment, coupled with the expanding patient population base.
Get Free 10% Customization on Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174360683 The neonatal jaundice management segment is estimated to hold the largest share of the global phototherapy equipment market owing to the huge neonate patient pool for jaundice, high cost and risk associated with exchange transfusion treatment, use of phototherapy as the primary treatment for neonatal jaundice, and positive reimbursement scenario in developed countries.
Distinctive market improvement activities and business methodologies utilized by industry players to beat macroeconomic conditions, including new thing/organization progression, joint undertakings, associations, unions and acquisitions, and so forth, are referred to in the report.
The association profiles for the Worldwide Ophthalmic Occluder Market contain a business diagram, thing/organization commitments, SWOT Analysis, part and full scale pay, gross edge, and percent piece of the general business.To clarify the moving toward adventure pockets, the assessment recalls for significance examination, most recent things, and future guesses of the Ophthalmic Occluder Market.
The parts that drive and limit the advancement of the Ophthalmic Occluder Market are altogether reviewed.
Porter’s Five Forces study complements the power of buyers and suppliers in aiding accomplices in making fundamental business decisions and choosing the level of industry force.
Expansive assessments of key mechanical areas help in understanding the different sorts of things and advances used in different bits of the world.In light of districts, the Ophthalmic Occluder Market report covers the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a piece of the Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as an element of South America.Get a Sample Copy of the Report to understand the structure of the complete reporthttps://www.oneupbusinessinsights.com/request_sample.php?tname=316848Top key players: Gulden Ophthalmics, Good-Lite, Blundell Harling, Precision Vision, GOLGATHA company, and Elbee Medical DevicesSegmentation of Ophthalmic Occluder Market:Product Type CoveragePlasticAlloyApplication CoverageHospitalClinicOtherOphthalmic Occluder Market: Regional Segment AnalysisMore Information:The report includes :1.)
The Asia Ophthalmic Occluder Market;3.)
Many organisations provide Australia and New Zealand Custom Procedure Trays and Packs.
Botox, facelifts, laser hair removal, rhinoplasty, and a variety of other cosmetic treatments are all performed with these trays.
The major purpose of these trays is to keep the skin safe while the treatment is being performed.
They do, however, differ in terms of style.
Some are small and sleek, while others are big and cartoonish in appearance.These Australia and New Zealand Custom Procedure Trays and Packs may usually be bought online.
They can be bought with particular instructions and information about the procedures that can be performed on them.During a procedure, custom trays are utilised to retain materials under the patient's teeth.
A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global smoke evacuation systems market was worth USD 114.3 million in the year 2020.
The data generated by the study revealed the market is estimated to grow at a CAGR of 6.5%, earning revenue of around USD 176.5 million by the end of 2027.
Smoke evacuation systems are in high demand due to the increase in surgical procedures and the increasing use of heat-generating medical devices and equipment.
However, the growth is still limited in emerging economies such as India, Japan, China, etc.
Countries like South Korea and China are becoming hubs for cosmetic and dermatologic surgeries, which means the local industry, as well as global players, are exposed to enormous opportunities to become the leading smoke evacuation systems manufacturer.Recommendation by Government and Professional OrganizationsMany government and professional organizations are making recommendations for the efficient use of medical equipment and devices while also ensuring the safety of healthcare professionals and hospital staff.
For instance, Occupational Safety and Health Organization (OSHA) recommends the adoption of smoke evacuation systems for ensuring maximum safety at the surgical sites.Global Smoke Evacuation Systems Market - By End-UserBased on end-users, the global smoke evacuation systems market is segmented into hospitals, ambulatory surgery centers, cosmetic surgery centers, dental clinics, and veterinary healthcare providers.
